BORSANI, Oscar
 Distribuzione geografica
Continente #
NA - Nord America 172
AS - Asia 97
EU - Europa 85
SA - Sud America 15
AF - Africa 2
Totale 371
Nazione #
US - Stati Uniti d'America 172
CN - Cina 40
SG - Singapore 38
IT - Italia 21
FI - Finlandia 20
BR - Brasile 13
DE - Germania 11
IE - Irlanda 10
AT - Austria 7
HK - Hong Kong 6
CH - Svizzera 5
RU - Federazione Russa 4
VN - Vietnam 4
JP - Giappone 3
GB - Regno Unito 2
PL - Polonia 2
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
EG - Egitto 1
FR - Francia 1
IN - India 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
NL - Olanda 1
QA - Qatar 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 371
Città #
Ashburn 33
New York 29
Shanghai 24
Boardman 21
Helsinki 20
Singapore 20
Dublin 10
Beijing 9
Chandler 7
Hong Kong 6
Nuremberg 5
Los Angeles 4
Milan 4
Vienna 4
Brugherio 3
Lugano 3
Tokyo 3
Falkenstein 2
Hanoi 2
Paderno Dugnano 2
Rio de Janeiro 2
Seattle 2
Washington 2
Baku 1
Basel 1
Bishkek 1
Bogotá 1
Buenos Aires 1
Buffalo 1
Cairo 1
Changsha 1
Chicago 1
Curitiba 1
Doha 1
Forest City 1
Frankfurt am Main 1
Kayseri 1
Lawrence 1
London 1
Medford 1
Messias 1
Newark 1
Paris 1
Pavia 1
Pilar 1
Piracicaba 1
Piscataway 1
Princesa Isabel 1
Princeton 1
Pune 1
Puyang Chengguanzhen 1
Riga 1
Rome 1
Santa Albertina 1
Sarandi 1
Sidrolândia 1
Sorocaba 1
São Lourenço do Sul 1
São Paulo 1
Zurich 1
Totale 254
Nome #
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 52
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 30
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 30
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis 27
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms 26
Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver 25
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients 24
Isolated congenital asplenia: An overlooked cause of thrombocytosis 22
COVID-19 in Patients with Hematologic Diseases 17
Wandering Spleen: An Unusual Cause of Recurrent Abdominal Pain 16
Breakthrough infections in MPN-COVID vaccinated patients 16
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients 15
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19 15
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 14
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms 14
Long-term follow-up of recovered MPN patients with COVID-19 14
Incidence of blast phase in myelofibrosis according to anemia severity 11
Second versus first wave of COVID-19 in patients with MPN 11
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project 8
Primary Budd-Chiari Syndrome 7
Erythrocytosis in congenital heart defects: hints for diagnosis and therapy from a clinical case 4
The evolutionary journey from essential thrombocythaemia to acute erythroid leukaemia 3
Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms 3
Totale 404
Categoria #
all - tutte 3.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 3 0 0 0 0 0 0 0 0 0
2021/20223 0 0 0 0 0 0 0 0 0 0 1 2
2022/202350 2 2 0 2 2 1 0 1 10 0 26 4
2023/2024186 11 27 9 8 18 61 23 9 4 4 8 4
2024/2025162 19 22 8 2 1 19 42 23 26 0 0 0
Totale 404